Kratom carries real health risks, but the picture is more nuanced than a simple yes or no. At low doses (1 to 5 grams), it acts as a mild stimulant. At higher doses (5 to 15 grams), it produces opioid-like sedation and pain relief. That dose-dependent shift matters because the higher you go, the more the risks stack up: liver injury, heart rhythm changes, dependence, and dangerous interactions with other drugs.
How Kratom Works in the Body
Kratom’s two main active compounds, mitragynine and 7-hydroxymitragynine, bind to the same receptors in the brain that opioids like morphine and fentanyl target. But they bind much more weakly. Mitragynine has roughly 89 times less binding strength at these receptors than fentanyl and about 170 times less than morphine. At the receptor level, mitragynine doesn’t actually activate the opioid response at all. It’s the second compound, 7-hydroxymitragynine, that does the heavy lifting, acting as a partial activator with about 41% of the maximum effect that full opioids like fentanyl or morphine produce.
This partial activation is why kratom’s effects feel milder than prescription opioids, and it’s also why some researchers have been interested in its potential for managing opioid withdrawal. But “milder than fentanyl” is not the same as safe. Partial activation of opioid receptors still produces dependence, sedation, and respiratory effects, especially at high doses or when combined with other substances.
Liver Injury
Kratom can damage the liver. The typical pattern shows up within 1 to 8 weeks of regular use and starts with fatigue, nausea, itching, and dark urine, followed by jaundice (yellowing of the skin and eyes). The liver injury tends to affect bile flow rather than destroying liver cells outright, though it can become severe. In documented cases, bilirubin levels (a marker of how well the liver processes waste) have climbed above 20 mg/dL, which is more than 15 times the normal upper limit and indicates serious dysfunction.
Not everyone who uses kratom will develop liver problems, and the exact rate isn’t well established. But because kratom is sold as an unregulated supplement with no standardized dosing, the risk is difficult to predict for any individual user.
Heart Rhythm and Cardiovascular Effects
The most commonly reported cardiovascular effects from kratom are elevated heart rate and high blood pressure. Poison control data consistently flag these as the top heart-related complaints. More concerning, lab studies show that mitragynine can interfere with the electrical channels that keep your heartbeat regular, prolonging the interval between beats in a way that could trigger a dangerous rhythm called torsades de pointes.
In a clinical study of regular kratom users, 8% had elevated resting heart rates and 5% had prolonged electrical intervals on their heart tracings. Users were significantly more likely to have fast resting heart rates compared to non-users. The study found that regular consumption pushed heart rhythm intervals toward borderline territory in a dose-dependent way, meaning more kratom equaled longer intervals, though most users didn’t cross into the clearly dangerous range. A handful of case reports have linked kratom to cardiac arrest from abnormal heart rhythms, though these cases often involved other substances too.
Dangerous Drug Interactions
This is one of kratom’s most underappreciated risks. Mitragynine powerfully inhibits a liver enzyme called CYP3A, which is responsible for breaking down a wide range of common medications. It also strongly inhibits CYP2D6, another major drug-processing enzyme. When these enzymes are blocked, other drugs linger in your body at higher concentrations than expected, sometimes dramatically so.
Pharmacokinetic modeling based on a typical 2-gram kratom dose predicts that blood levels of certain medications could increase by the following amounts:
- Buspirone (an anxiety medication): up to 14 times normal levels
- Felodipine (a blood pressure drug): about 5 times normal
- Cyclosporine (an immune suppressant): about 4.5 times normal
- Alprazolam (a benzodiazepine): about 2.4 times normal
- Zolpidem (a sleep aid): about 1.6 times normal
At least one kratom-related death has been linked to toxic concentrations of quetiapine, an antipsychotic metabolized by CYP3A. If you take any prescription medications, combining them with kratom could push their levels into a toxic range without any warning.
Dependence and Withdrawal
Regular kratom use can produce physical dependence. In one U.S. survey, fewer than 10% of kratom users overall reported withdrawal symptoms, though the rate was higher among people who had started using kratom to manage opioid dependence. Withdrawal symptoms overlap with both opioid and stimulant withdrawal: runny nose, muscle pain, diarrhea, lethargy, depressed mood, and anxiety.
Clinical observations suggest that kratom withdrawal is less intense than withdrawal from prescription opioids like hydromorphone or oxycodone, but more drawn out. One well-documented case described a man who used kratom to manage opioid withdrawal and found it considerably milder, but the kratom withdrawal that followed lasted longer. This pattern makes sense given kratom’s partial activation of opioid receptors: the ceiling on its effects is lower, so the rebound is gentler but can drag on.
Overdose Deaths
CDC data from a 27-state review covering July 2016 through December 2017 identified 152 overdose deaths where kratom was detected in toxicology. Medical examiners ruled kratom a contributing cause in 91 of those deaths. In only 7 of those 91 cases was kratom the sole substance detected, and even in those cases, the presence of undetected additional substances couldn’t be ruled out. Nearly all kratom-positive deaths involved other drugs.
This doesn’t mean kratom alone can’t kill you, but it does suggest that the highest risk comes from combining kratom with other substances, particularly opioids, benzodiazepines, and other sedatives. Given how strongly kratom inhibits the enzymes that process many of these drugs, the combination can be far more dangerous than either substance alone.
Contamination in Commercial Products
Because kratom is sold as an unregulated botanical product, quality control varies enormously. FDA testing of commercial kratom products found high levels of heavy metals, including lead, nickel, arsenic, chromium, cobalt, and vanadium, in nearly all samples analyzed. Several samples contained lead and nickel at concentrations exceeding safe daily exposure limits. The FDA has also tested kratom products for salmonella contamination, and a 2018 outbreak linked to contaminated kratom sickened dozens of people across multiple states.
Without standardized manufacturing requirements, buyers have no reliable way to know what’s actually in a given product. Two packages of the same brand could contain different alkaloid concentrations, different contaminant levels, and different adulterants.
Why Some People Use It Anyway
A significant number of kratom users report taking it to manage chronic pain or to taper off opioid medications. The pharmacology supports the logic: kratom’s partial activation of opioid receptors can blunt withdrawal symptoms and reduce cravings without producing the full intensity of traditional opioids. Case reports describe people successfully using kratom to bridge gaps when prescription opioids were unavailable, with withdrawal that was less severe than what they’d experienced from pharmaceutical opioids.
This self-treatment approach is not without its own risks, though. Users are essentially substituting one opioid-receptor-targeting substance for another, with no medical oversight, no standardized dosing, and a product that may contain toxic contaminants. The line between “using kratom to get off opioids” and “developing a kratom dependence” can be thin, especially at higher doses taken over months or years.
Legal Status in the U.S.
Kratom is not federally scheduled in the United States, but several states have banned it outright, and others have local restrictions. A growing number of states have passed the Kratom Consumer Protection Act, which doesn’t ban kratom but sets age restrictions and product quality standards. The patchwork of laws means legality depends entirely on where you live, and legal availability shouldn’t be mistaken for a signal of safety. The FDA has repeatedly declined to approve kratom for any medical use and has issued multiple warnings about its risks.